Biosupply Trends Marketplace News
Monday, June 18, 2018
Banner Image - Patient Safety, Product Integrity, Fair Pricing
biosupply button green pixel top of biosupply button Spacer image top of Verified Inventory Program button
Biosupply, place your product order Spacer image MyFluVaccine, place your vaccine order Spacer image Verified Inventory Program, sign up for streamlined inventory

Study Finds No Link Between HPV Vaccine and Autoimmune Disorders Risk

female getting needle injected by doctor
 

In this Issue
•  IVIG/Albumin Supply Index
•  Open Market Pricing
•  New Products from FFF
•  Current Medicare
IVIG / SCIG Rates
•  Resources
•  Subscribe to IG Living and BioSupply Trends Quarterly
 

There is no increased risk of autoimmune disorders in girls who receive the quadrivalent human papillomavirus (HPV4) vaccine, according to a study published in the Canadian Medical Association Journal. [ read more ]

New 10% IVIG Being Tested for Pediatric and Adult PI Patients

Evolve Biologics has dosed the first pediatric patient in its Phase III multicenter clinical trial of PlasmaCap IG (intravenous immune globulin [IVIG]), in addition to having administered half of the infusions required for the adult portion of the study, which completed enrollment in February. [ read more ]

Updated C. Diff Guidelines Reflect New Treatment Options and Recommendations

The Infectious Diseases Society of America and Society for Healthcare Epidemiology of America have updated guidelines for diagnosis and management of Clostridium difficile, which has become the leading cause of diarrhea in hospital patients and one of the most common healthcare-associated infections that sickens nearly 500,000 Americans and is associated with 15,000 to 30,000 deaths annually. [ read more ]

Industry News

 
blue molecules
 

From Grifols

New automated diagnostic tests for lupus and ANCA-associated vasculitis, a form of blood vessel inflammation, have been approved by the U.S. Food and Drug Administration. [ read more ]

From Novartis

Novartis's Gilenya (fingolimod) has been approved by the U.S. Food and Drug Administration (FDA) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. Gilenya is the first FDA approval of a drug to treat MS in pediatric patients.  [ read more ]

From Octapharma USA

For the second consecutive year, Octapharma USA will serve as the exclusive sponsor of the nation's only National Camp Exchange for the bleeding disorders community, an adjunct program of the North American Camping Conference of Hemophilia Organizations. [ read more ]

IVIG & Albumin Supply Index
IVIG and Albumin Supply Index from March 2018 - June 2018
 
Log in to BioSupply for IVIG and Albumin Product Pricing
 
 
 

NEW Issue of Biosupply Trends Quarterly!
BioSupplyTrends Quarterly Magazine cover
 
 

In this Issue
•  Banishing Burnout in the Healthcare Setting
•  The Evolution of Medical Aid in Dying
•  Are Drugs Really Overpriced?
•  Healthcare Data: Ensuring Regulatory Compliance
•  Myths and Facts: Cataracts
     
  Subscribe to Biosupply Trends Quarterly Magazine  
     

MyFluVaccine Loyalty Program
Want priority access on flu vaccines
for the 2019-2020 season?
blue handshake hands

Then take advantage of our NEW inclusive MFV Loyalty Program and enroll for the 2019-2020 season when you go to book your flu vaccine orders for the 2018-2019 season through MyFluVaccine.com

  • Priority access on advance released flu vaccines
  • No minimum purchase
  • Hassle-free
  • Guaranteed booking for the products you need

What's New at FFF
• CROFAB® (BTG INTERNATIONAL)

CROFAB Crotalidae Polyvalent Immune Fab (Ovine) is indicated for the management of adult and pediatric patients with North American crotalid (Crotalinae subfamily of venomous snakes that includes rattlesnakes, copperheads and cottonmouths/water moccasins) envenomation. It is supplied as a lyophilized powder in vials that contain up to 1 gram of total protein, a maximum of 0.03 mg of mercury, and not less than the indicated number of mouse LD neutralizing units.

For more information about CROFAB, login to biosupply.fffenterprises.com

• HYPERRAB® (GRIFOLS)

HYPERRAB is a human rabies immune globulin (RIG) indicated for postexposure prophylaxis, along with rabies vaccine, for persons suspected of exposure to rabies. The new formulation, approved by the U.S. Food and Drug Administration in April, is twice the potency (300 IU/mL) of currently available RIG options, offering a greater concentration of anti-rabies virus antibodies within each mL of volume, meaning fewer injections for patients. It is available in two vial sizes: 1 mL/300 IU and 5 mL/1500 IU. And, although the new RIG is an advancement in patient care, the cost of treatment remains the same as the original product.

For more information about HYPERRAB, login to biosupply.fffenterprises.com

These products can be ordered from FFF Enterprise's BioSupply Online Ordering System or by calling
Wow! Customer Care at (800) 843-7477.

Current Medicare IVIG / SCIG Rates

Rates per gram are effective Apr. 1, 2018, through Jun. 30, 2018.
 
Calculate your current medicare IVIG/SCIG Rates
Product J Codes ASP + 6%
(before sequester)		 ASP + 4.3%*
(after sequester)
IVIG
Carimune NF J1566 $71.06 $69.92
Flebogamma J1572 $70.29 $69.16
Gammagard S/D J1566 $71.06 $69.92
Gammaplex J1557 $78.19 $76.93
Octagam J1568 $82.81 $81.49
Privigen J1459 $79.30 $78.03
SCIG
CUVITRU J1555 $135.25 $133.08
Hizentra J1559 $98.33 $96.75
HyQvia J1575 $138.59 $136.37
IVIG / SCIG
Gammagard Liquid J1569 $79.38 $78.10
Gammaked J1561 $78.29 $77.03
Gamunex-C J1561 $78.29 $77.03

*Reflects 2% sequestration reduction applied to 80% Medicare payment portion as required under Budget Control Act of 2011.
 
Log in to BioSupply for Immune Globulin Products

Resources

FFF customers may order the following complementary resources to help you with your practice:
Seasonal Flu Poster flu myths and facts brochure
immune globulin reference charts
•  IG Immune Globulin (Human)
•  Hyperimmune Globulins
•  Anti-Inhibitor, Factor VIIa & IX
•  Factor VIII & von Willebrand Factor
•  Seasonal Influenza Vaccine

Subscribe to IG Living

IG Living is the only magazine for the immune globulin (IG) community for patients who suffer from chronic illness and their caregivers.

Subscribe to IG Living
IG Living Magazine cover
BioSupplyTrends Quarterly Magazine cover

Subscribe to BioSupply
Trends Quarterly

BioSupply Trends Quarterly magazine is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace.

Subscribe to Biosupply Trends Quarterly Magazine
small Biosupply logo small MyFluVaccine logo Verified Inventory Program logo
Home | About | Advertise | Subscribe | Contact – ©2018 FFF Enterprises, Inc.